These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4276011)

  • 21. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

  • 22. [I. Evaluation of the hypothalamo-hypophyseal-adrenal function. Effects of the administration of ACTH, dexamethasone, metopirone and L-dopa on the steroids of urine in normal patients].
    Charro Salgado AL; Bagazgoitia J; López Macia A; Oriol Bosch A; Fernández Cruz A
    Rev Clin Esp; 1976 May; 141(3):221-6. PubMed ID: 180569
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fluctuations of plasma concentration of growth hormone (GH) and cortisol in man during administration of L-DOPA. Fluctuations of plasma concentration of cortisol in dogs during administration of dopamine into the 3d ventricle].
    Yozai S; Takahara J; Hanabusa M; Ofuji T
    Horumon To Rinsho; 1972 Jun; 20(6):495-501. PubMed ID: 4673195
    [No Abstract]   [Full Text] [Related]  

  • 24. [Obesity and the somatotropic hormone. I. Somatotropin secretion in obesity].
    Giordano G; Foppiani E; Minuto F; Marugo M
    Folia Endocrinol; 1974 Aug; 27(4):339-68. PubMed ID: 4408078
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of L-dopa in the detection of presymptomatic Huntington's chorea.
    Klawans HL; Paulson GW; Ringel SP; Barbeau A
    N Engl J Med; 1972 Jun; 286(25):1332-4. PubMed ID: 4260358
    [No Abstract]   [Full Text] [Related]  

  • 26. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
    Massara F; Camanni F; Molinatti GM
    Horm Metab Res; 1973 Nov; 5(6):454-6. PubMed ID: 4767002
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypothalamo-pituitary function in Pickwickian syndrome.
    Smirne S; Reschini E; Giustina G
    Bull Physiopathol Respir (Nancy); 1972; 8(5):1021-8. PubMed ID: 4657861
    [No Abstract]   [Full Text] [Related]  

  • 28. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
    Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
    J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
    Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
    Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 31. Huntington's chorea--the rigid form (Westphal variant) treated with l-DOPA: a case report.
    Low PA; Allsop JL
    Proc Aust Assoc Neurol; 1973; 10(0):45-6. PubMed ID: 4275960
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of L-dopa on plasma growth hormones and insulin.
    Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
    Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects.
    Mims RB; Stein RB; Bethune JE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):34-9. PubMed ID: 4715294
    [No Abstract]   [Full Text] [Related]  

  • 35. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 36. [Behavior of plasmatic HGH after stimulation with L-Dopa in normal elderly subjects and in subjects with cerebrovascular disorders: preliminary study].
    Bellastella A; Cafaro MR; Colucci CF; D'Alessandro B; Gasbarro R
    Boll Soc Ital Biol Sper; 1973 May; 49(10):586-91. PubMed ID: 4788780
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of L-dopa on plasma HGH, LH, FSH and 11-OH-CS in normal adult subjects.
    Delitala G; Masala A; Rolandi E
    Folia Endocrinol; 1974 Jun; 27(3):279-89. PubMed ID: 4406495
    [No Abstract]   [Full Text] [Related]  

  • 38. [Fatty acid patterns and glucose tolerance in Huntington's chorea (author's transl)].
    Schubotz R; Hausmann L; Kaffarnik H; Zehner J; Oepen H
    Res Exp Med (Berl); 1976 Jul; 167(3):203-15. PubMed ID: 136033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of synthetic somatotropin release inhibiting factor on the increase in plasma growth hormone elicited by L-dopa in the dog.
    Lovinger R; Boryczka AT; Shackelford R; Kaplan SL; Ganong WF; Grumbach MM
    Endocrinology; 1974 Oct; 95(4):943-6. PubMed ID: 4606498
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth-hormone secretion in patients with endometrial carcinoma.
    Benjamin F; Casper DJ; Sherman L; Kolodny HD
    N Engl J Med; 1969 Dec; 281(26):1448-52. PubMed ID: 5353308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.